Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-p-activated nitric oxide donor PABA/NO in malignant gliomas
  2. Kogias, E.; Osterberg, N.; Baumer, B.; Psarras, N.; Koentges, C.; Papazoglou, A.; Saavedra, J. E.; Keefer, L. K.; Weyerbrock, A.
  3. International Journal of Cancer. 2012, Mar; 130(5): 1184-1194.
  1. 2.   JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells
  2. McMurtry, V.; Saavedra, J. E.; Nieves-Alicea, R.; Simeone, A. M.; Keefer, L. K.; Tari, A. M.
  3. International Journal of Oncology. 2011, Apr; 38(4): 963-971.
  1. 3.   Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases
  2. da Fonseca, R. R.; Johnson, W. E.; O'Brien, S. J.; Vasconcelos, V.; Antunes, A.
  3. Bmc Evolutionary Biology. 2010, Sep; 10: 11.
  1. 4.   Arsenic-Specific Stem Cell Selection During Malignant Transformation
  2. Tokar, E. J.; Qu, W.; Liu, J.; Liu, W.; Webber, M. M.; Phang, J. M.; Waalkes, M. P.
  3. Journal of the National Cancer Institute. 2010, May; 102(9): 638-649.
  1. 5.   Stabilization of the Nitric Oxide (NO) Prodrugs and Anticancer Leads, PABA/NO and Double JS-K, through Incorporation into PEG-Protected Nanoparticles
  2. Kumar, V.; Hong, S. Y.; Maciag, A. E.; Saavedra, J. E.; Adamson, D. H.; Prud'homme, R. K.; Keefer, L. K.; Chakrapani, H.
  3. Molecular Pharmaceutics. 2010, Jan-Feb; 7(1): 291-298.
  1. 6.   Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells
  2. Liu, J.; Malavya, S.; Wang, X. Q.; Saavedra, J. E.; Keefer, L. K.; Tokar, E.; Qu, W.; Waalkes, M. P.; Shami, P. J.
  3. Genomics. 2009 94(1): 32-38.
  1. 7.   The Nitric Oxide Prodrug JS-K and Its Structural Analogues as Cancer Therapeutic Agents
  2. Maciag, A. E.; Saavedra, J. E.; Chakrapani, H.
  3. Anti-cancer agents in medicinal chemistry. 2009 9(7): 798-803.
  1. 8.   Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound
  2. Nandurdikar, R. S.; Maciag, A. E.; Citro, M. L.; Shami, P. J.; Keefer, L. K.; Saavedra, J. E.; Chakrapani, H.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(10): 2760-2762.
  1. 9.   GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese
  2. Guo, X. C.; O'Brien, S. J.; Zeng, Y.; Nelson, G. W.; Winkler, C. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(7): 1760-1763.
  1. 10.   JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
  2. Kiziltepe, T.; Hideshima, T.; Ishitsuka, K.; Ocio, E. M.; Raje, N.; Catley, L.; Li, C. Q.; Trudel, L. J.; Yasui, H.; Vallet, S.; Kutok, J. L.; Chauhan, D.; Mitsiades, C. S.; Saavedra, J. E.; Wogan, G. N.; Keefers, L. K.; Shami, P. J.; Anderson, K. C.
  3. Blood. 2007, Jul; 110(2): 709-718.
  1. 11.   Environmental genotoxicants/carcinogens and childhood cancer: Bridgeable gaps in scientific knowledge
  2. Anderson, L. M.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2006, Sep; 608(2): 136-156.
  1. 12.   Antitumor activity of JS-K O-2-(2,4-dinitrophenyl) 1- (4-ethoxycarbonyl)piperazin-1-yl diazen-1-ium-1,2-diolate and related O-2-Aryl diazeniumdiolates in vitro and in vivo
  2. Shami, P. J.; Saavedra, J. E.; Bonifant, C. L.; Chu, J. X.; Udupi, V.; Malaviya, S.; Carr, B. I.; Kar, S.; Wang, M. F.; Jia, L.; Ji, X. H.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 2006, Jul; 49(14): 4356-4366.
  1. 13.   Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors
  2. De Roos, A. J.; Rothman, N.; Brown, M.; Bell, D. A.; Pittman, G. S.; Shapiro, W. R.; Selker, R. G.; Fine, H. A.; Black, P. M.; Inskip, P. D.
  3. Neuro-Oncology. 2006, Apr; 8(2): 145-155.
  1. 14.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 15.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 16.   Making the most of affinity tags
  2. Waugh, D. S.
  3. Trends in Biotechnology. 2005, JUN; 23(6): 316-320.
  1. 17.   Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype
  2. Kowara, R.; Karaczyn, A.; Cheng, R. Y. S.; Salnikow, K.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2005, MAY 15; 205(1): 1-10.
  1. 18.   Structural basis for the function of stringent starvation protein A as a transcription factor
  2. Hansen, A. M.; Gu, Y. J.; Li, M.; Andrykovitch, M.; Waugh, D. S.; Jin, D. J.; Ji, X. H.
  3. Journal of Biological Chemistry. 2005, APR 29; 280(17): 17380-17391.
  1. 19.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 20.   Crystal structure of human glutathione S-transferase A3-3 and mechanistic implications for its high steroid isomerase activity
  2. Gu, Y. J.; Guo, J. X.; Pal, A.; Pan, S. S.; Zimniak, P.; Singh, S. V.; Ji, X. H.
  3. Biochemistry. 2004, DEC 21; 43(50): 15673-15679.
  1. 21.   CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women
  2. Yang, X. H. R.; Wacholder, S.; Xu, Z. Y.; Dean, M.; Clark, V.; Gold, B.; Brown, L. M.; Stone, B. J.; Fraumeni, J. F.; Caporaso, N. E.
  3. Cancer Letters. 2004, OCT 28; 214(2): 197-204.
  1. 22.   The dMRP/CG6214 gene of Drosophila is evolutionarily and functionally related to the human multidrug resistance-associated protein family
  2. Tarnay, J. N.; Szeri, F.; Ilias, A.; Annilo, T.; Sung, C.; Le Saux, O.; Varadi, A.; Dean, M.; Boyd, C. D.; Robinow, S.
  3. Insect Molecular Biology. 2004, OCT; 13(5): 539-548.
  1. 23.   Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 162-174.
  1. 24.   Specific excision of the selenocysteine tRNA([Ser]Sec) (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function
  2. Carlson, B. A.; Novoselov, S. V.; Kumaraswamy, E.; Lee, B. J.; Anver, M. R.; Gladyshev, V. N.; Hatfield, D. L.
  3. Journal of Biological Chemistry. 2004 279(9): 8011-8017.
  1. 25.   Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug
  2. Findlay, V. J.; Townsend, D. M.; Saavedra, J. E.; Buzard, G. S.; Citro, M. L.; Keefer, L. K.; Ji, X. H.; Tew, K. D.
  3. Molecular Pharmacology. 2004 65(5): 1070-1079.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel